Succinic acid and derivatives for the treatment of haemotological disorders
AssigneeEnzene Biosciences Limited
InventorsHimanshu GADGIL, Abir BANERJEE, Arindam CHAKRABORTY, Mazin ADENWALA
Life of this patent
Estimating the term…
Loading patent…
AssigneeEnzene Biosciences Limited
InventorsHimanshu GADGIL, Abir BANERJEE, Arindam CHAKRABORTY, Mazin ADENWALA
Estimating the term…
The present invention relates to succinic acid and its derivative(s) of Formula (I), their pharmaceutically acceptable salts, polymorphs, solvates, hydrates, co-crystals, isomers and solvates thereof as an active pharmaceutical ingredient for the treatment of haematological disorder(s). The present invention further relates to compounds of Formula (I), for the treatment of disorders selected from dengue, idiopathic thrombocytopenic purpura (ITP), anaemia and chemotherapy induced myelosuppression. The present invention also relates to use of succinic acid for the treatment of haematological disorder(s), wherein succinic acid is extracted from Papaya leaves. The present invention also provides pharmaceutical compositions comprising succinic acid and its derivative(s) of Formula I and methods of treating haematological disorder(s).
Use of Succinic acid and its derivatives of Formula (I), their pharmaceutically acceptable salts, polymorphs, solvates, hydrates, co-crystals, isomers and solvates thereof,
A method for the treatment of haematological disorders selected from dengue, idiopathic thrombocytopenic purpura (ITP) and anaemia chemotherapy induced myelosuppression, comprising administering a pharmaceutically effective amount of the compounds of Formula I, their pharmaceutically acceptable salts, polymorphs, solvates, hydrates, co-crystals, isomers and solvates to a subject in need thereof,
A pharmaceutical composition, comprising compounds of Formula I, their pharmaceutically acceptable salts, polymorphs, solvates, hydrates, co-crystals, isomers and solvates thereof,
Dependencies are inferred from the claim text.